Background and Hypothesis:Approximately 16% of the American population suffers from overactive bladder, with 25-40% patients reporting unsatisfactory results following first line treatments. Sacral neuromodulation is a well-established, minimally invasive treatment option for several forms bladder bowel dysfunction that are non-responsive to pharmacologic or behavioral therapies. While more bro...
